← All trials
NCT06573528
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 30, 2024
- Primary completion
- Mar 12, 2025
- Completion date
- Jun 10, 2025
- First posted
- Aug 27, 2024
- Last posted
- Aug 27, 2024
- Enrollment
- 80
- Arms / groups
- 10 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Jiao Tong UniversityOfficial
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.